PL2343281T3 - Sposób syntezy pochodnych fenoksydiaminopirymidyny - Google Patents

Sposób syntezy pochodnych fenoksydiaminopirymidyny

Info

Publication number: PL2343281T3
Authority: PL; Poland
Prior art keywords: synthesis; diaminopyrimidine derivatives; phenoxy; phenoxy diaminopyrimidine; derivatives
Prior art date: 2006-10-04

Application number

PL10180595T

Other languages

English (en)

Inventor

Charles Dvorak

Keena Lynn Green

Gary R Lee

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-10-04

Filing date

2007-09-24

Publication date

2014-08-29

2007-09-24 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2014-08-29 Publication of PL2343281T3 publication Critical patent/PL2343281T3/pl

Links

IBEQALXTSLPKDO-UHFFFAOYSA-N O(C1=CC=CC=C1)C1=NC(=CC(=N1)N)N Chemical class O(C1=CC=CC=C1)C1=NC(=CC(=N1)N)N IBEQALXTSLPKDO-UHFFFAOYSA-N 0.000 title 1
230000015572 biosynthetic process Effects 0.000 title 1
238000000034 method Methods 0.000 title 1
238000003786 synthesis reaction Methods 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Urology & Nephrology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)
Neurosurgery (AREA)
Reproductive Health (AREA)
Rheumatology (AREA)
Diabetes (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Hydrogenated Pyridines (AREA)
Pyridine Compounds (AREA)

PL10180595T 2006-10-04 2007-09-24 Sposób syntezy pochodnych fenoksydiaminopirymidyny PL2343281T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US84920306P	2006-10-04	2006-10-04
EP07820502.8A EP2079713B1 (en)	2006-10-04	2007-09-24	Process for synthesis of phenoxy diaminopyrimidine derivatives
EP10180595.0A EP2343281B1 (en)	2006-10-04	2007-09-24	Process for synthesis of phenoxy diaminopyrimidine derivatives

Publications (1)

Publication Number	Publication Date
PL2343281T3 true PL2343281T3 (pl)	2014-08-29

Family

ID=39004835

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL10180595T PL2343281T3 (pl)	2006-10-04	2007-09-24	Sposób syntezy pochodnych fenoksydiaminopirymidyny

Country Status (15)

Country	Link
US (3)	US8003788B2 (pl)
EP (2)	EP2343281B1 (pl)
JP (2)	JP5128603B2 (pl)
KR (1)	KR101176701B1 (pl)
CN (2)	CN102432548A (pl)
AU (1)	AU2007304280B2 (pl)
BR (1)	BRPI0719955B1 (pl)
CA (1)	CA2664305C (pl)
DK (1)	DK2343281T3 (pl)
ES (2)	ES2461595T3 (pl)
IL (3)	IL197639A (pl)
MX (1)	MX2009003257A (pl)
PL (1)	PL2343281T3 (pl)
SI (1)	SI2343281T1 (pl)
WO (1)	WO2008040652A1 (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP5128603B2 (ja) *	2006-10-04	2013-01-23	エフ．ホフマン−ラロシュアーゲー	フェノキシジアミノピリミジン誘導体の合成方法
CR20160093A (es)	2013-08-23	2016-08-26	Afferent Pharmaceuticals Inc	Moduladores del receptor p2x3 y p2x2/3 de diaminopiridina para el tratamiento de la tos aguda, sub aguda o cronica
CN105085847B (zh) *	2014-05-23	2018-05-04	中国科学院宁波材料技术与工程研究所	一种磺酰胺化芳香族聚合物、其制备方法及应用
US10195198B2 (en)	2014-07-03	2019-02-05	Afferent Pharmaceuticals, Inc.	Methods and compositions for treating diseases and conditions
PT3355889T (pt)	2015-09-29	2023-04-26	Afferent Pharmaceuticals Inc	Moduladores de recetores de diaminopirimidina p2x3 e p2x2/3 para utilização no tratamento da tosse
CA3018180C (en) *	2016-03-25	2024-02-20	Ronald Charles Hawley	Pyrimidines and variants thereof, and uses therefor
US10676444B2 (en) *	2016-12-20	2020-06-09	Afferent Pharmaceuticals, Inc.	Crystalline salts and polymorphs of a P2X3 antagonist
AU2019257606B2 (en) *	2018-04-23	2025-01-30	Msd Werthenstein Biopharma Gmbh	Novel process for synthesis of a phenoxy diaminopyrimidine compound
SG11202111877TA (en)	2019-04-30	2021-11-29	Beijing Tide Pharmaceutical Co Ltd	Method for treating cough by using diaminopyrimidine compound
CN111635368B (zh) *	2020-06-12	2021-06-29	东莞市东阳光仿制药研发有限公司	一种胺化合物的制备方法
EP4214195A1 (en)	2020-09-17	2023-07-26	Teva Pharmaceuticals International GmbH	Solid state forms of gefapixant and process for preparation thereof
CN113336680B (zh) *	2021-06-04	2023-10-03	寿光永康化学工业有限公司	一种磺胺的绿色工艺合成方法
CN113773300B (zh) *	2021-09-27	2022-10-11	成都施贝康生物医药科技有限公司	磺酰胺类化合物、其制备方法及用途
CN113801097B (zh) *	2021-09-27	2022-11-22	成都施贝康生物医药科技有限公司	二氢嘧啶类化合物、其制备方法及用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FI972194A7 (fi) *	1994-11-24	1997-05-22	Basilea Pharmaceutica Ag	Uusia bentsyylipyrimidiinejä
AUPQ968700A0 (en) *	2000-08-28	2000-09-21	Intreat Pty Limited	Treatment of urinary incontinence
EP1541575B1 (en) *	2002-07-29	2010-03-03	Sumitomo Chemical Company, Limited	Novel process for producing imidazo(1,2-b)pyridazine derivative
ES2391636T3 (es) *	2004-03-05	2012-11-28	F. Hoffmann-La Roche Ag	Diaminopirimidinas como antagonistas de P2X3 y P2X2/3
SE0401716D0 (sv) *	2004-07-02	2004-07-02	Astrazeneca Ab	New compounds
ES2343640T3 (es) *	2004-08-12	2010-08-05	Amgen Inc.	Bisaril-sulfonamidas.
JP4246207B2 (ja) *	2005-02-21	2009-04-02	住友化学株式会社	除草剤組成物
KR101012926B1 (ko) *	2005-09-01	2011-02-09	에프. 호프만-라 로슈 아게	Ｐ2ｘ3 및 ｐ2ｘ2/3 조정자로서의 다이아미노피리미딘
CN101253158B (zh) *	2005-09-01	2013-07-10	弗·哈夫曼-拉罗切有限公司	合成芳氧基二氨基嘧啶类化合物的方法
JP5128603B2 (ja) *	2006-10-04	2013-01-23	エフ．ホフマン−ラロシュアーゲー	フェノキシジアミノピリミジン誘導体の合成方法
WO2008104474A1 (en) *	2007-02-28	2008-09-04	F. Hoffmann-La Roche Ag	Diaminopyrimidines

2007
- 2007-09-24 JP JP2009530844A patent/JP5128603B2/ja active Active
- 2007-09-24 SI SI200731458T patent/SI2343281T1/sl unknown
- 2007-09-24 CN CN2011103315372A patent/CN102432548A/zh active Pending
- 2007-09-24 AU AU2007304280A patent/AU2007304280B2/en active Active
- 2007-09-24 CN CN2007800373077A patent/CN101522641B/zh active Active
- 2007-09-24 CA CA2664305A patent/CA2664305C/en active Active
- 2007-09-24 WO PCT/EP2007/060095 patent/WO2008040652A1/en not_active Ceased
- 2007-09-24 EP EP10180595.0A patent/EP2343281B1/en active Active
- 2007-09-24 MX MX2009003257A patent/MX2009003257A/es active IP Right Grant
- 2007-09-24 ES ES10180595.0T patent/ES2461595T3/es active Active
- 2007-09-24 PL PL10180595T patent/PL2343281T3/pl unknown
- 2007-09-24 DK DK10180595.0T patent/DK2343281T3/en active
- 2007-09-24 BR BRPI0719955-4A patent/BRPI0719955B1/pt active IP Right Grant
- 2007-09-24 ES ES07820502.8T patent/ES2466667T3/es active Active
- 2007-09-24 KR KR1020097008196A patent/KR101176701B1/ko active Active
- 2007-09-24 EP EP07820502.8A patent/EP2079713B1/en active Active
- 2007-10-04 US US11/906,802 patent/US8003788B2/en active Active
2009
- 2009-03-17 IL IL197639A patent/IL197639A/en active IP Right Grant
2011
- 2011-07-12 US US13/181,305 patent/US8580960B2/en active Active
2012
- 2012-09-05 JP JP2012194914A patent/JP5669793B2/ja active Active
2013
- 2013-10-14 US US14/053,362 patent/US9643934B2/en active Active
2014
- 2014-09-09 IL IL234545A patent/IL234545A/en active IP Right Grant
2017
- 2017-09-11 IL IL254426A patent/IL254426A0/en unknown

Also Published As

Publication number	Publication date
US20110269961A1 (en)	2011-11-03
MX2009003257A (es)	2009-04-07
US8003788B2 (en)	2011-08-23
IL197639A0 (en)	2009-12-24
SI2343281T1 (sl)	2014-06-30
EP2343281B1 (en)	2014-03-05
EP2079713A1 (en)	2009-07-22
IL254426A0 (en)	2017-11-30
JP2013010780A (ja)	2013-01-17
AU2007304280B2 (en)	2013-01-31
CN101522641B (zh)	2012-07-04
CN101522641A (zh)	2009-09-02
BRPI0719955A2 (pt)	2014-04-29
EP2079713B1 (en)	2014-04-16
KR101176701B1 (ko)	2012-08-23
BRPI0719955B1 (pt)	2024-01-09
DK2343281T3 (en)	2014-03-24
CA2664305A1 (en)	2008-04-10
ES2466667T3 (es)	2014-06-10
US9643934B2 (en)	2017-05-09
KR20090055043A (ko)	2009-06-01
US8580960B2 (en)	2013-11-12
JP5669793B2 (ja)	2015-02-18
JP5128603B2 (ja)	2013-01-23
CN102432548A (zh)	2012-05-02
WO2008040652A1 (en)	2008-04-10
IL234545A (en)	2017-10-31
EP2343281A1 (en)	2011-07-13
ES2461595T3 (es)	2014-05-20
US20080086004A1 (en)	2008-04-10
IL197639A (en)	2015-02-26
JP2010505790A (ja)	2010-02-25
US20140045871A1 (en)	2014-02-13
AU2007304280A1 (en)	2008-04-10
CA2664305C (en)	2016-06-07

Publication	Publication Date	Title
IL254426A0 (en)	2017-11-30	A process for the preparation of phenoxy diaminopyrimidine derivatives
IL194508A0 (en)	2009-08-03	Process for synthesizing organoelemental compounds
IL198847A0 (en)	2010-02-17	New process for the preparation of 2-imino-thiazolidin-4-one derivatives
IL185419A0 (en)	2008-01-06	Improved process for the synthesis of enantiomeric indanylamine derivatives
ZA200903533B (en)	2010-03-31	Process for the preparation of rosuvastatin
PL2121577T3 (pl)	2013-12-31	Sposób syntezy kwasów omega-aminoalkanowych
PL1893586T3 (pl)	2009-03-31	Sposób wytwarzania 1-alkilo-3-fenylouracyli
GB0702854D0 (en)	2007-03-28	Method for the synthesis of sucrose-6-esters
ZA200903889B (en)	2010-03-31	Process for the synthesis of moxifloxacin hydrochloride
ZA201000482B (en)	2011-07-27	Process for the synthesis of e1 activating enzyme inhibitors
IL220430A0 (en)	2012-07-31	Process for the production of benzopyran-2-ol derivatives
EG25867A (en)	2012-09-12	Enhanced process for the synthesis of urea
PL2213654T3 (pl)	2014-06-30	Sposób wytwarzania pochodnych 2-amino-5-bromobenzamidu
IL198117A0 (en)	2009-12-24	Process for preparing indol-5-oxy-quinazoline derivatives and intermediates
TWI339991B (en)	2011-04-01	Method for virtual bass synthesis
IL196474A0 (en)	2009-12-24	Improved process for the preparation of voriconazole
IL205082A0 (en)	2010-11-30	Process for the preparation of tetranorlabdane derivatives
PL2102174T3 (pl)	2017-09-29	Sposób wytwarzania pochodnych podstawionych cyjanofenoksy-pirymidynyloksyfenyloakrylanów
ZA200806840B (en)	2010-01-27	Improved process for producing nitroisourea derivatives
ZA200806839B (en)	2009-11-25	Improved process for producing nitroguanidine derivatives
PL2137202T3 (pl)	2017-12-29	Sposób syntezy IB-MECA
TWI368621B (en)	2012-07-21	Stereoselective synthesis of β-nucleosides
GB2459413B (en)	2012-02-01	Methods for the synthesis of perfluoroparacyclophane
IL194330A0 (en)	2009-08-03	Processes for the synthesis of 3-isobutylglutaric acid
SI2038260T1 (sl)	2011-01-31	Stereoselektivna sinteza (S)-1-metil-3-fenilpiperazina